⌘K

Home/Filings/4/0001104659-22-025704

4//SEC Filing

TUCHMAN ALAN J 4

Accession 0001104659-22-025704

CIK 0001571934other

View on SEC.gov Company Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:01 PM ET

Size

5.5 KB

Accession

0001104659-22-025704

Insider Transaction Report

Form 4

Period: 2022-02-16

Synaptogenix, Inc.SNPX

DirectorChief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-16+6,150→ 6,150 total
Exercise: $7.29Exp: 2032-02-16→ Common Stock (6,150 underlying)

Footnotes (1)

[F1]This option was issued on February 16, 2022 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan and will vest in equal quarterly installments over the four quarters following the Grant Date.

Documents

1 file

4
tm227375-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1

filerCIK 0001417631

Filing Metadata

Form type: 4
Filed: Feb 21, 7:00 PM ET
Accepted: Feb 22, 5:01 PM ET
Size: 5.5 KB

View on SEC.gov